BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 38494858)

  • 21. Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells.
    Zhang L; Zhang J; Jin Y; Yao G; Zhao H; Qiao P; Wu S
    Front Cell Dev Biol; 2021; 9():728172. PubMed ID: 34589492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promising potential of boron compounds against Glioblastoma: In Vitro antioxidant, anti-inflammatory and anticancer studies.
    Turkez H; Arslan ME; Tatar A; Mardinoglu A
    Neurochem Int; 2021 Oct; 149():105137. PubMed ID: 34293392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis.
    Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N
    Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative Stress in Cancer Cell Metabolism.
    Arfin S; Jha NK; Jha SK; Kesari KK; Ruokolainen J; Roychoudhury S; Rathi B; Kumar D
    Antioxidants (Basel); 2021 Apr; 10(5):. PubMed ID: 33922139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptive Changes Allow Targeting of Ferroptosis for Glioma Treatment.
    Huang R; Dong R; Wang N; He Y; Zhu P; Wang C; Lan B; Gao Y; Sun L
    Cell Mol Neurobiol; 2022 Oct; 42(7):2055-2074. PubMed ID: 33893939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Potential Mechanism of Temozolomide Resistance in Glioma-Ferroptosis.
    Hu Z; Mi Y; Qian H; Guo N; Yan A; Zhang Y; Gao X
    Front Oncol; 2020; 10():897. PubMed ID: 32656078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative Stress in Cancer.
    Hayes JD; Dinkova-Kostova AT; Tew KD
    Cancer Cell; 2020 Aug; 38(2):167-197. PubMed ID: 32649885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic Alterations of Heat Shock Proteins (HSPs) in Cancer.
    Ban HS; Han TS; Hur K; Cho HS
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells.
    Chen Y; Mi Y; Zhang X; Ma Q; Song Y; Zhang L; Wang D; Xing J; Hou B; Li H; Jin H; Du W; Zou Z
    J Exp Clin Cancer Res; 2019 Sep; 38(1):402. PubMed ID: 31519193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Concentrations of Boric Acid Trigger Concentration-Dependent Oxidative Stress, Apoptotic Pathways and Morphological Alterations in DU-145 Human Prostate Cancer Cell Line.
    Hacioglu C; Kar F; Kacar S; Sahinturk V; Kanbak G
    Biol Trace Elem Res; 2020 Feb; 193(2):400-409. PubMed ID: 31066018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nrf2 in cancers: A double-edged sword.
    Wu S; Lu H; Bai Y
    Cancer Med; 2019 May; 8(5):2252-2267. PubMed ID: 30929309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Genome-wide Haploid Genetic Screen Identifies Regulators of Glutathione Abundance and Ferroptosis Sensitivity.
    Cao JY; Poddar A; Magtanong L; Lumb JH; Mileur TR; Reid MA; Dovey CM; Wang J; Locasale JW; Stone E; Cole SPC; Carette JE; Dixon SJ
    Cell Rep; 2019 Feb; 26(6):1544-1556.e8. PubMed ID: 30726737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis.
    Dodson M; Castro-Portuguez R; Zhang DD
    Redox Biol; 2019 May; 23():101107. PubMed ID: 30692038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boron Neutron Capture Therapy of Malignant Gliomas.
    Miyatake SI; Kawabata S; Hiramatsu R; Kuroiwa T; Suzuki M; Ono K
    Prog Neurol Surg; 2018; 32():48-56. PubMed ID: 29990973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities.
    Jung BJ; Yoo HS; Shin S; Park YJ; Jeon SM
    Biomol Ther (Seoul); 2018 Jan; 26(1):57-68. PubMed ID: 29212307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hsp70: A Cancer Target Inside and Outside the Cell.
    Boudesco C; Cause S; Jego G; Garrido C
    Methods Mol Biol; 2018; 1709():371-396. PubMed ID: 29177673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide.
    Zhang L; Wang H
    Pharmacol Rep; 2017 Dec; 69(6):1186-1193. PubMed ID: 29128799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. All-trans retinoic acid enhances temozolomide-induced autophagy in human glioma cells U251 via targeting Keap1/Nrf2/ARE signaling pathway.
    Shi L; Li H; Zhan Y
    Oncol Lett; 2017 Sep; 14(3):2709-2714. PubMed ID: 28927033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.